Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Michael Perkinton


Michael is a project director in Neurodegeneration at AstraZeneca based in Cambridge and is a member of the DPUK Company Partner Forum.

Recent publications

More publications